1 Describe the pathology and epidemiologic proportions of erectile dysfunction (ED). 2 De®ne appropriate diagnostic evaluation of ED. 3 Describe the process of care for ED patients. 4 Understand the mechanisms of action and drug safety and ef®cacy for currently approved and developmental-stage therapies and their relevance to patient care. 5 Demonstrate increased awareness about surgical interventions for severe ED related to such disorders as Peyronie's Disease.
Target audience
The conference proceedings contained in this issue of the International Journal of Impotence Research are designed to meet the educational needs of urologists and general practitioners who wish to gain more knowledge in the area of diagnosis, treatment and holistic management of the male with erectile dysfunction.
CME post-test questions: First International Conference on the Management of Erectile Dysfunction
Select the correct answer to each of the following questions and record your responses on the CME answer sheet and evaluation form. A) Patients with CV disease may present special safety risks yet these are the patients who should be carefully evaluated. B) Patients with co-morbidities related to CV disease are likely to demand currently available ED treatments. C) Sexual activity may precipitate a CV event. D) All of the above.
7 Drugs that enhance corporal smooth muscle relaxation are, in theory, effective as erectogenic agents because:
A) Corporal smooth muscle contraction is inhibited by PGE 1 . B) Corporal cavernosal smooth muscle relaxation allows the attainment of suf®cient pressure to compress subtunical veins and prevent egress of blood from the cavernosa. C) Cardiac and peripheral vascular tissues are not rich in type V PDE. D) The major pathway for smooth muscle relaxation is the NO-cGMP pathway.
8 The side effect of nausea usually associated with apomorphine is tolerable when administered sublingually in 2 or 4 mg doses as evidenced by:
A) Minimal use of anti-emetics during placebocontrolled studies. B) Declining effects of nausea with repeated use. C) Nausea was mild and had no effect on ef®cacy. D) All of the above.
9 Melanotan II would be an important clinical advance in the treatment of ED if not for:
A) The interaction with anti-hypertensive medications. B) High incidence of nausea. 14 During surgical penile remodeling procedures, the following should be avoided:
A) Producing an audible crack when the penile plaque is straightened. B) Using the Otis urethrotome to broaden the caliber of scarred corporal bodies. C) Replacing the entire penile implant every year because of wear-related failures. D) Prescribing sildena®l to patients post-operatively.
15 A three month trial of exogenous androgen (eg testosterone) therapy should not be considered for the treatment of ED if the patient:
A) Presents with a relatively normal serum T that is con®rmed with a repeat test. B) Has concurrent osteoporosis, hypogonadism and cardiovascular disease.
Self-assessment questions and evaluation C) Is suspected to have repeat prostate cancer or liver disease. D) All of the above.
16 Serum prolactin levels are worthwhile to obtain in diagnosing a patient with ED because:
A) It is a relatively inexpensive diagnostic test. B) Elevated prolactin is often associated with ED. C) Pituitary adenoma is a life threatening, rare, but readily reversible cause of ED that is detected by this method. D) It is more reliable than serum testosterone assays.
17 In patient with Peyronie's disease, when angulation cannot be corrected with a penile prosthesis alone, the following alternative procedure should be considered: C) The prevalence of sexual dysfunction in women is higher than in men. D) Post-menopausal women have fewer sexual problems than younger women. A) It is a peptide isolated from human phaeochromocytoma cells that has structural similarities to calcitonin-gene-related peptide. B) It may function as a hormone that regulates systemic arterial pressure. C) NO and KATP channels probably mediate the response of cavernosal tissue to adrenomedullin. D) It has been demonstrated to increase intracavernous pressure and penile length in cats.
Management of erectile dysfunction
Continuing education answer sheet and evaluation form Instructions 1 Read the journal carefully, including the selfassessment questions. 
